Skip navigation
Speakers

Uniting Payers, Providers and Manufacturers to Increase Market Access and Identify Value Ecosystems for Mature and Emerging Oncologic Therapies

February 28-March 1, 2018
  • San Francisco, CA

Chris Boneham
Executive Director, Managed Markets
Aralez Pharmaceuticals US Inc

Elizabeth K. Brooks
Partner
BioMedical Insights, Inc.

Lesly Charanza
Vice President, Market Access – Oncology
Heron Therapeutics

Joe Fuhr
Professor Emeritus of Economics, Widener University;
Adjunct Faculty, Thomas Jefferson University College of Population Health

George Hiller
Founder, The Hiller Pharmacy Group;
Former Executive Director, Pharmacy Benefit Management,
Blue Cross and Blue Shield of Alabama)

Dawn Holcombe, MBA, FACMPE
ACHE Director
NAMCP Medical Directors Institute Oncology Council

Chris Mancill
Vice President, Reimbursement-Oncology
EMD Serono

Scott Megaffin
President
Churchill Pharmaceuticals

Saikat Nandi, MS, PhD
Business Development Consultant
New York State Center for Biotechnology

Christopher Nicita
Partner
BioMedical Insights, Inc.

Robert Popovian, PharmD, MS
Vice President, US Government Relationsm
Pfizer Inc

Susanne M. Radke
Consultant, Medical Affairs and Lifescience Strategy
Medical Innovation in Context LLC

Sheldon J. Rich
President
SJR Associates, LLC

Erin A. Zagadailov, PharmD, MS
Associate Director, Global Pricing,
Market Access, and Health Economics
Takeda

Chris Boneham
Executive Director, Managed Markets
Aralez Pharmaceuticals US Inc

Elizabeth K. Brooks
Partner
BioMedical Insights, Inc.

Lesly Charanza
Vice President, Market Access – Oncology
Heron Therapeutics

Joe Fuhr
Professor Emeritus of Economics, Widener University;
Adjunct Faculty, Thomas Jefferson University College of Population Health

George Hiller
Founder, The Hiller Pharmacy Group;
Former Executive Director, Pharmacy Benefit Management,
Blue Cross and Blue Shield of Alabama)

Dawn Holcombe, MBA, FACMPE
ACHE Director
NAMCP Medical Directors Institute Oncology Council

Chris Mancill
Vice President, Reimbursement-Oncology
EMD Serono

Scott Megaffin
President
Churchill Pharmaceuticals

Saikat Nandi, MS, PhD
Business Development Consultant
New York State Center for Biotechnology

Christopher Nicita
Partner
BioMedical Insights, Inc.

Robert Popovian, PharmD, MS
Vice President, US Government Relationsm
Pfizer Inc

Susanne M. Radke
Consultant, Medical Affairs and Lifescience Strategy
Medical Innovation in Context LLC

Sheldon J. Rich
President
SJR Associates, LLC

Erin A. Zagadailov, PharmD, MS
Associate Director, Global Pricing,
Market Access, and Health Economics
Takeda